Uccioli L, Ghirlanda G, Cotroneo P, Bianchini G, Manto A, Solini A, Annese V, Greco A V
Peptides. 1986;7 Suppl 1:287-91. doi: 10.1016/0196-9781(86)90204-4.
Somatostatin has been proposed as a regulatory peptide of nutrient entry and fuel homeostasis because of its ability to inhibit the release of substances involved in food digestion and metabolism. The aim of the study was to evaluate the somatostatin response to a test meal in type I diabetics at the clinical onset of the disease and after two months of intensive insulin therapy. Normal subjects and diabetics in good metabolic control showed a characteristic biphasic somatostatin rise after a test meal; this response was lacking in diabetics at the onset of the disease. The response of somatostatin to a mixed meal in normals confirms its involvement in nutrient digestion and metabolism. The lacking somatostatin response in newly diagnosed type I diabetics might be related to deficient GIP response to the test meal or to other factors such as the insulinopenia or metabolic derangement characteristic of the clinical onset of the disease.
由于生长抑素能够抑制参与食物消化和代谢的物质释放,因此它被认为是一种调节营养物质摄入和能量稳态的调节肽。本研究的目的是评估Ⅰ型糖尿病患者在疾病临床发作时以及强化胰岛素治疗两个月后的生长抑素对试餐的反应。正常受试者和代谢控制良好的糖尿病患者在试餐后生长抑素呈现出典型的双相升高;而在疾病发作时的糖尿病患者中则缺乏这种反应。正常人生长抑素对混合餐的反应证实了其参与营养物质的消化和代谢。新诊断的Ⅰ型糖尿病患者缺乏生长抑素反应可能与对试餐的GIP反应不足或其他因素有关,如疾病临床发作时的胰岛素缺乏或代谢紊乱。